
Current Price | $119.44 | Mkt Cap | $20.8B |
---|---|---|---|
Open | $121.69 | P/E Ratio | 85.78 |
Prev. Close | $119.44 | Div. (Yield) | $4.90 (4.2%) |
Daily Range | $118.65 - $121.69 | Volume | 1,258,990 |
52-Wk Range | $90.73 - $172.65 | Avg. Daily Vol. | 1,299,659 |
The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.
Current Price | $119.44 | Mkt Cap | $20.8B |
---|---|---|---|
Open | $121.69 | P/E Ratio | 85.78 |
Prev. Close | $119.44 | Div. (Yield) | $4.90 (4.2%) |
Daily Range | $118.65 - $121.69 | Volume | 1,258,990 |
52-Wk Range | $90.73 - $172.65 | Avg. Daily Vol. | 1,299,659 |
The best Bull and Bear pitches based on recency and number of recommendations.
I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.
Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.
Read the most recent pitches from players about ARE.
Recs
I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.
Recs
Growth reit in healthcare
Recs
This pick gets exposure to the biotech/pharma industries without investment in a specific company. Rather, ARE is a REIT that builds out laboratory space for up and coming companies.
Find the members with the highest scoring picks in ARE.
TrackJMP (< 20) Score: +238.61
The Score Leader is the player with the highest score across all their picks in ARE.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Macademia | 89.50 | 1/20/2009 |
![]() |
1Y | $35.77 | +234.27% | +456.02% | +221.76 | 2 Comments | |
brgr1 | 77.97 | 8/27/2008 |
![]() |
1Y | $64.81 | +84.48% | +272.26% | +187.78 | 0 Comment | |
mamabourne | 96.18 | 8/7/2008 |
![]() |
3M | $65.44 | +82.72% | +270.20% | +187.48 | 0 Comment | |
ScreenerStizBear | 51.84 | 6/27/2008 |
![]() |
NS | $60.17 | +98.71% | +269.81% | +171.10 | 1 Comment | |
Camel2414 | < 20 | 6/12/2008 |
![]() |
3M | $61.00 | +96.01% | +254.03% | +158.03 | 0 Comment | |
itsoeasy | 87.56 | 4/24/2008 |
![]() |
NS | $62.81 | +90.35% | +247.62% | +157.26 | 0 Comment | |
bilderberger | < 20 | 3/17/2008 |
![]() |
3Y | $53.09 | +125.23% | +278.92% | +153.69 | 3 Comments | |
Jesse500v | 91.39 | 5/5/2008 |
![]() |
3W | $63.40 | +88.59% | +238.35% | +149.76 | 0 Comment | |
loudoungroup | < 20 | 12/17/2008 |
![]() |
NS | $31.90 | +274.76% | +422.04% | +147.28 | 0 Comment | |
TrackOptionAddct | 89.85 | 3/10/2008 |
![]() |
3W | $53.47 | +123.61% | +269.47% | +145.86 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.